Disclosed herein is a method of taste masking a fluoroquinolone preferably one selected from the group of ciprofloxacin gatifloxacin gemifloxacin norfloxacin moxifloxacin marbofloxacin orbifloxacin sparfloxacin tosufloxacin trovafloxacin pefloxacin lomefloxacin clinafloxacin prulifloxacin sarafloxacin sitafloxacin and pazufloxacin; the method comprising combining the fluoroquinolone with an amount of a divalent or trivalent cation sufficient to mask the taste of the fluoroquinolone. Suitable cat...

PROBLEM TO BE SOLVED: To provide a method for masking the characteristic uncomfortable taste of a quinolone-based antibiotic in an oral administration liquid medicine.SOLUTION: This quinolone-based antibiotic oral administration liquid medicine is characterized by comprising a quinolone-based antibiotic selected from enoxacin lomefloxacin ofloxacin gatifloxacin ciprofloxacin sparfloxacin tosufloxacin fleroxacin levofloxacin and norfloxacin an organic acid selected from acetic acid and lactic aci...

FIELD: medicine pharmaceutics. ^ SUBSTANCE: invention refers to medicine and pharmaceutical industry. A pharmaceutical composition for outward application for treating allergic and inflammatory skin diseases contains a glucocorticosteroid specified in a group: mometasone or its derivatives betametasone or its derivatives beclometasone or its derivatives dexametasone or its derivatives flumetasone or its derivatives; as an antibacterial quinolone compound it contains a compound specified in a gro...

The present invention relates to an aqueous pharmaceutical composition comprising a) 0.01 to 30 percent by weight of a quinolone compound being selected from the group consisting of orbifloxacin grepafloxacin nalidixic acid sparfloxacin or trovafloxacin mesylate b) 0.2 to 20 percent by weight of an ion exchange resin prepared from a porous copolymer of methacrylic acid crosslinked with divinylbenzene and c) pharmaceutically acceptable excipients to equal 100 percent.